Jones v. Eli Lilly and Company

CourtDistrict Court, D. Maryland
DecidedSeptember 30, 2021
Docket8:20-cv-03564
StatusUnknown

This text of Jones v. Eli Lilly and Company (Jones v. Eli Lilly and Company) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jones v. Eli Lilly and Company, (D. Md. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Southern Division

TANJANEKA JONES, *

Plaintiff, * v. Case No.: GJH-20-3564 * ELI LILLY AND COMPANY, * Defendant. * * * * * * * * * * * * * *

MEMORANDUM OPINION

Plaintiff Tanjaneka Jones filed this lawsuit against her former employer Defendant Eli Lilly and Company (“Eli Lilly”), alleging race and sex discrimination in violation of Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e, et seq. (“Title VII”), Section 1981 of the Civil Rights Act of 1866, 42 U.S.C. § 1981 (“Section 1981”), and the Maryland Fair Employment Practices Act (“MFEPA”), Md. Code Ann., State Gov’t § 20-606,1 retaliation in violation of Title VII and MFEPA § 20-606, hostile work environment/ harassment in violation of Title VII and MFEPA § 20-606, and retaliation in violation of the Family Medical Leave Act of 1993, 29 U.S.C. 2601, et seq. (“FMLA”). ECF No. 3. Several motions are pending before the Court, including Defendant’s Motion to Dismiss Plaintiff’s Amended Complaint, ECF No. 12, and Plaintiff’s Motion for Leave to Amend, ECF No. 18.2 No hearing is necessary. See Loc. R. 105.6

1 In Plaintiff’s Amended Complaint, ECF No. 3, and proposed Second Amended Complaint, ECF No. 18-1, Plaintiff asserts claims under “§ 120-606” of the Maryland Fair Employment Practices Act, which does not exist. The Court understands this to be an error and interprets Plaintiff’s claims under § 20-606.

2 Also pending before the Court is Plaintiff’s Consent Motion for Extension of Time to File Response/ Reply as to Defendant’s Motion to Dismiss Plaintiff’s Amended Complaint, ECF No. 13, and Defendant’s Motion to Withdraw as Attorney, ECF No. 22, which the Court now grants. (D. Md. 2021). For the following reasons, Plaintiff’s Motion for Leave to Amend, ECF No. 18, is denied, in part, and granted, in part; and Defendant’s Motion to Dismiss Plaintiff’s Amended Complaint, ECF No. 12, is granted, in part, and denied, in part. I. BACKGROUND3

A. Factual Background

Plaintiff, a Black female, began working as a Senior Sales Representative (“SSR”) at Eli Lily, in or around 2014, where her primary duty was to sell pharmaceutical products. ECF No. 18-1 ¶ 6. At Eli Lilly, business sales controlled the SSR’s income, benefits, and other opportunities. Id. The Second Amended Complaint additionally alleges that yearly pay increases, quarterly bonuses, and the SSR’s national and team ranking were based on sales performance. Id. ¶ 7. Therefore, Plaintiff’s sales results were tracked by Defendant weekly, monthly, and quarterly to determine quarterly sales bonuses and payouts, and Defendant awarded annual “Achievement trips” based on sales, specifically for reaching “100% quota attain on primary sales products annually.” Id. Defendant also offered yearly awards based on individual sales achievements that were recognized at its “annual Regional Meeting for Representative of the Year, Rookie of the Year, Outstanding Sales Performance for Jardiance,” among others, and this recognition opened other opportunities for SSRs to obtain job advancement and pay increases. Id. Plaintiff alleges that she “met or exceeded her performance goals in sales” as required by Defendant Eli Lilly. ECF No. 3 ¶ 6; see also ECF No. 18-1 ¶8.

3 Unless stated otherwise, all facts are taken from Plaintiff’s proposed Second Amended Complaint or documents attached to and relied upon in the proposed Second Amended Complaint and are accepted as true. See E.I. du Pont de Nemours & Co. v. Kolon Indus., Inc., 637 F.3d 435, 440 (4th Cir. 2011). In or around May 2019, David Sun, an Asian male, began supervising Plaintiff’s team. ECF No. 18-1 ¶ 8. At that time, the team was one of Defendant’s top five teams in the country and Plaintiff was ranked number two on her team and was exceeding Defendant’s sales goal by nine percent. Id. Plaintiff alleges that despite her success, Sun placed her on a Performance Improvement Plan (PIP), after supervising her for one month, and “overly scrutinized and

criticized Plaintiff’s work performance” and “relied on false and subjective reasons to discipline her.” ECF No. 18-1 ¶ 9. Plaintiff further alleges that Sun did not overly scrutinize or criticize the performance of Douglas Barna and Brandon Fell, both Caucasian male SSRs under his supervision, who Plaintiff alleges had “far lower sales and sales rankings” than she did. ECF No. 18-1 ¶ 10. Plaintiff also alleges that, though he failed to meet Defendant’s sales quota, Fell was not placed on a PIP like Plaintiff. Id. In or around June 2019, Plaintiff learned that Sun scrutinized and criticized Krystle Allen, a female SSR, who met Defendant’s sales quotas as Plaintiff had, and thereafter Plaintiff contacted Defendant’s Human Resources (“HR”) representatives “several times” between June

2019 and November 2019 requesting assistance. ECF No. 18-1 ¶ 11. In or around October 2019, Plaintiff spoke with HR and stated that “Mr. Sun was discriminating against her because of her race and gender by overly scrutinizing and criticizing her work performance as compared to her Caucasian male colleagues and placing her on a PIP for false reasons.” ECF No. 18-1 ¶ 12. Plaintiff also informed HR that Allen, who also exceeded sales goals, was “overly scrutinized and criticized” by Sun, as compared to Fell and Barna. Id. Though Plaintiff requested the assistance of HR, she contends that HR failed to help her and that, after HR spoke with Sun about Plaintiff’s October 15, 2019 complaint, Sun “placed Plaintiff on probation [and] took away her bonus opportunity on or about October 16, 2019,” making her ineligible for vacancies and promotions with Defendant. Id. ¶ 13. She also alleges that Sun increased his scrutiny and critique of her performance and gave her a poor performance evaluation despite her increasing sales numbers and praise from clients. Id. As a result of this treatment, Plaintiff filed a charge of discrimination with the Equal Employment Opportunity Commission (“EEOC”) in November 2019, ECF No. 18-1 ¶ 14, after

which Plaintiff contends Sun’s “harassment of her increased and began occurring almost every week.” Id. ¶ 15. Plaintiff contends that her “workplace felt more and more hostile because she was being disciplined for false reasons,” instead of being congratulated for exceeding her sales goals and that, “due to Mr. Sun’s discriminatory write-ups,” her bonuses were revoked for “consecutive months beginning in October 2019,” even though she was ranked second on her sales team. Id. Plaintiff also alleges that Sun discriminated against William White and Brian Calloway, two Black SSRs also on his team, who Plaintiff alleges were also meeting sales goals. Id. ¶ 17. Similar to Sun’s treatment of Plaintiff, he “overly scrutinized and criticized their performance

and subsequently discharged or constructively discharged them for discriminatory reasons.” Id. Further, Plaintiff alleges that Sun treated Barna and Fell, the Caucasian SSRs who had lower sales, “more favorably than the two Black SSRs,” and that although Fell was below his sales quotas set by Defendant, “he was not discharged or constructively discharged like the Black male SSRs.” Id. ¶ 18. Plaintiff alleges that “Defendant allowed Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Saint Francis College v. Al-Khazraji
481 U.S. 604 (Supreme Court, 1987)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
Oubre v. Entergy Operations, Inc.
522 U.S. 422 (Supreme Court, 1998)
Burlington Industries, Inc. v. Ellerth
524 U.S. 742 (Supreme Court, 1998)
Pennsylvania State Police v. Suders
542 U.S. 129 (Supreme Court, 2004)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
CBOCS West, Inc. v. Humphries
553 U.S. 442 (Supreme Court, 2008)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Bonds v. Leavitt
629 F.3d 369 (Fourth Circuit, 2011)
Russell, Lisa K. v. Principi, Anthony J.
257 F.3d 815 (D.C. Circuit, 2001)
Hoyle v. FREIGHTLINER, LLC
650 F.3d 321 (Fourth Circuit, 2011)
Okoli v. City of Baltimore
648 F.3d 216 (Fourth Circuit, 2011)
Paul Carter v. William L. Ball, III
33 F.3d 450 (Fourth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Jones v. Eli Lilly and Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jones-v-eli-lilly-and-company-mdd-2021.